home / stock / kzia / kzia quote
Last: | $0.21 |
---|---|
Change Percent: | 5.95% |
Open: | $0.2055 |
Close: | $0.1982 |
High: | $0.2298 |
Low: | $0.2015 |
Volume: | 168,197 |
Last Trade Date Time: | 06/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.21 | $0.2055 | $0.1982 | $0.2298 | $0.2015 | 168,197 | 06-26-2024 |
$0.1982 | $0.2305 | $0.1982 | $0.231 | $0.1952 | 573,258 | 06-25-2024 |
$0.226 | $0.269 | $0.226 | $0.28 | $0.2197 | 412,811 | 06-24-2024 |
$0.2676 | $0.2533 | $0.2676 | $0.27 | $0.2502 | 65,114 | 06-21-2024 |
$0.27 | $0.245 | $0.27 | $0.2783 | $0.24001 | 157,843 | 06-20-2024 |
$0.2411 | $0.2478 | $0.2411 | $0.262 | $0.23 | 313,672 | 06-19-2024 |
$0.2411 | $0.2478 | $0.2411 | $0.262 | $0.23 | 313,672 | 06-18-2024 |
$0.23 | $0.229 | $0.23 | $0.2496 | $0.2285 | 206,796 | 06-17-2024 |
$0.230065 | $0.2577 | $0.230065 | $0.2577 | $0.1923 | 508,373 | 06-14-2024 |
$0.2423 | $0.259899 | $0.2423 | $0.26 | $0.240098 | 93,698 | 06-13-2024 |
$0.2499 | $0.26 | $0.2499 | $0.2636 | $0.2411 | 138,183 | 06-12-2024 |
$0.2621 | $0.2601 | $0.2621 | $0.268787 | $0.2501 | 17,021 | 06-11-2024 |
$0.267 | $0.2554 | $0.267 | $0.2741 | $0.24515 | 73,961 | 06-10-2024 |
$0.2495 | $0.2512 | $0.2495 | $0.258599 | $0.2412 | 81,829 | 06-07-2024 |
$0.25435 | $0.266 | $0.25435 | $0.27 | $0.2407 | 175,797 | 06-06-2024 |
$0.266 | $0.2489 | $0.266 | $0.27 | $0.2489 | 47,109 | 06-05-2024 |
$0.2502 | $0.2636 | $0.2502 | $0.2636 | $0.2406 | 80,414 | 06-04-2024 |
$0.2699 | $0.2624 | $0.2699 | $0.2699 | $0.2522 | 60,120 | 06-03-2024 |
$0.26 | $0.252 | $0.26 | $0.2776 | $0.24 | 187,734 | 05-31-2024 |
$0.2497 | $0.24 | $0.2497 | $0.2598 | $0.24 | 114,109 | 05-30-2024 |
News, Short Squeeze, Breakout and More Instantly...
Kazia Therapeutics Limited Company Name:
KZIA Stock Symbol:
NASDAQ Market:
Kazia Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement PR Newswire SYDNEY , May 23, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) (Kazia or the company) received a letter on May 22, 2024 from Nasdaq notifying the ...
KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS PR Newswire SYDNEY , May 1, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specialising in oncology, is pleased t...
2024-04-05 10:30:00 ET April 5, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech/Life Sciences sector. The newest biotech companies offer therapies for cancer, eye di...